Heart Failure, Congestive Clinical Trial
Official title:
Functional Circuit Training in Older Adults With Congestive Heart Failure
The goal of this study is to determine the effect of a functional circuit training program as compared to standard cardiac rehabilitation or control exercise in improving physical function and activity.
In older (65 years of age or older) patients with congestive heart failure, we propose to:
1. Assess: a) Peak aerobic capacity (peak VO2) during a monitored, standardized treadmill
test; b) Oxygen uptake kinetics and heart rate during a standardized submaximal
treadmill test; c) Performance on a set of functional mobility tasks; d) Self-report of
physical disability and difficulty in performing daily tasks, and physical activity.
2. Conduct a 12-week randomized controlled trial, comparing changes in these assessed
measures in patients randomized to three different groups: 1) standard cardiac
rehabilitation using bicycle exercise; 2) group functional circuit training focusing on
exercises that involve functional mobility tasks and a home-activities exercise
component; 3) a chair-based, flexibility and "toning " (low level resistance) group
control exercise.
3. Reassess all groups after an additional 12 weeks in the measures identified above to
identify how well the three groups maintain their function.
4. Examine the mechanisms underlying change in functional mobility performance and
self-reported function as a result of the interventions
Primary hypothesis 1: Compared to chair-based exercise controls at the end of week 12, both
the cardiac rehabilitation and functional circuit training groups will show improvements in
measures of peak aerobic capacity, submaximal oxygen uptake kinetics, functional mobility
performance, and self-reported function.
Primary hypothesis 2: Compared to the other two groups that are given exercise instructions
only, the functional circuit training group, who continue their home activities exercise
program, show less decline by week 24 in measures of peak aerobic capacity, submaximal
oxygen uptake kinetics, functional mobility performance, and self-reported function.
Secondary hypothesis: Measures of submaximal oxygen uptake kinetics are better predictors of
changes in functional mobility performance and self-reported function than peak aerobic
capacity, muscle strength, joint range of motion, balance, and behavioral factors (such as
depression).
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01357850 -
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
|
Phase 2 | |
Recruiting |
NCT00532688 -
N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal Failure
|
Phase 2/Phase 3 | |
Completed |
NCT00531661 -
CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients
|
N/A | |
Terminated |
NCT00383630 -
Bone Marrow Cell Transplantation to Improve Heart Function in Individuals With End-Stage Heart Failure
|
Phase 2 | |
Completed |
NCT00149435 -
Cardiovascular Health Study (CHS) Events Follow-up Study
|
||
Completed |
NCT00241761 -
Epidemiology of Depression and Heart Failure in Aging
|
N/A | |
Completed |
NCT00159614 -
Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal Impairment
|
Phase 2 | |
Terminated |
NCT00125437 -
Larger Dose of Spironolactone for the Treatment of Patients With Nonischemic Cardiomyopathy
|
N/A | |
Terminated |
NCT00357591 -
Randomized Trial for Patients With Chronic Heart Failure With Acute Decompensation
|
N/A | |
Completed |
NCT00202579 -
Efficacy and Safety of Ivabradine in Severe Congestive Heart Failure
|
Phase 2 | |
Completed |
NCT00094263 -
Long-Term Predictors of Morbidity in Older Age
|
N/A | |
Completed |
NCT00048425 -
Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.
|
Phase 3 | |
Completed |
NCT00530426 -
Heart Failure Registry
|
Phase 4 | |
Completed |
NCT00023556 -
Genetic Architecture of Heart Disease in Rural Brazil
|
N/A | |
Terminated |
NCT00190359 -
Growth Hormone and Heart Failure
|
N/A | |
Completed |
NCT00004562 -
Occluded Artery Trial (OAT)
|
Phase 3 | |
Completed |
NCT00005265 -
Natural History of Coronary Heart Disease
|
N/A | |
Completed |
NCT02772068 -
Hemodynamic Response to Exercise in HFpEF Patients After Upregulation of SERCA2a
|
Early Phase 1 | |
Completed |
NCT02925546 -
A Phase I Study to Assess the Pharmacokinetics of GSK2798745 Tablets
|
Phase 1 | |
Completed |
NCT01074307 -
A Prospective, Open-labeled, Multi-centric Trial in Subjects With Systolic Heart Failure to Evaluate Bisoprolol Treatment for the Effects on Surrogate Markers of Heart Failure in Korea
|
Phase 4 |